[支持在全身性硬化症中进行自身造血干细胞移植的论点]
1Service de médecine interne et immunologie clinique, CHU de Toulouse, 2, rue Viguerie, 31059 Toulouse, France.
概括
自主造血干细胞移植显著改善了严重系统性硬化症患者的生存率和生活质量. 这种治疗提供了一个重要的治疗选择,尽管存在潜在风险,但超越了其他方法.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 系统性硬化皮质是一种严重的自身免疫性疾病,治疗选择有限.
- 自主造血干细胞移植 (AHSCT) 已在25年内开发用于全身性硬皮病.
- 之前的治疗方法并没有对死亡率产生显著影响.
研究的目的:
- 评估AHSCT在患有严重扩散性皮肤全身性硬化症的患者的疗效和安全性.
- 为了比较AHSCT与静脉注射环胺在生存和生活质量方面.
- 评估AHSCT后的长期结果和复发率.
主要方法:
- 分析了三项随机对照临床试验.
- 收集了无事件生存率,总生存率和器官参与度的数据.
- 对接受AHSCT的患者进行了生活质量评估,与对照组相比.
主要成果:
- AHSCT在无事件生存率,总生存率和减少皮肤和肺部参与度方面显著改善.
- 接受AHSCT治疗的患者报告生活质量比接受IV环胺治疗的患者更好.
- 移植相关死亡率在2.4%至10%之间,复发率在两年内在9%至24%之间.
结论:
- 对于严重系统性硬化皮肤病患者来说,AHSCT提供了显著的生存益处和改善生活质量.
- 没有其他免疫抑制剂或生物药物在这种疾病中显示出可比的死亡率益处.
- 现在,AHSCT已被公认为一种1A级的基于证据的治疗方法,用于严重,早期和快速进展的全身性硬化皮肤病.
相关概念视频
Bone Marrow Sampling and Transplants
331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


